Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer — dosimetric and biokinetic aspects |
| |
Authors: | Kalevi J. A. Kairemo Hans A. Ramsay Magnus Tagesson Antti P. Jekunen Timo K. Paavonen Hilkka A. Jääskelä-Saari Kristian Liewendahl Kaj Ljunggren Sauli Savolainen Sven-Erik Strand |
| |
Affiliation: | (1) Department of Clinical Chemistry, University Central Hospital of Helsinki, Finland;(2) Department of Otorhinolaryngology, University Central Hospital of Helsinki, Finland;(3) Department of Oncology, University Central Hospital of Helsinki, Finland;(4) Department of Pathology, University of Helsinki, Finland;(5) Department of Physics, University of Helsinki, Finland;(6) Department of Radiation Physics, University of Lund, Sweden;(7) Division of Nuclear Medicine, Department of Clinical Chemistry, University Central Hospital, FIN-00290 Helsinki, Finland |
| |
Abstract: | Bleomycin (BLM) is used for the treatment of head and neck cancer. In order to improve the effectiveness of this chemotherapeutic drug, BLM was combined with indium-111. A complex of these agents (111In-BLMC), formed at low pH, was injected intravenously into ten head and neck cancer patients in escalating activities of 75, 175 and 375 MBq. The internally delivered dose to the tumours varied from 0.20 to 2.73 mGy at 75 MBq, from 0.33 to 2.51 mGy at 175 MBq, and from 0.87 to 31.3 mGy at the 375 MBq activity level. Uptake of radioactivity was 0.45±0.24×10–3% ID/g in primary tumours and 0.52±0.20×l0–3% ID/g in metastases (at 48 h). Tumour volumes varied from 0.51 to 49.0 cm3. The radioactivity half-lives in the tumours were 30±7 h. The activity distribution and penetration into tumour tissue were not affected by increasing the injected activity. There was a positive correlation between BLMC uptake and Ki-67/Mib activity as well as number of mitoses in tumour tissue. These data indicate that111In-BLMC has potential as a radiochemotherapeutic agent in head and neck cancer and that adjuvant Auger-electron therapy is possible using114m-In-labelled BLMC. |
| |
Keywords: | Bleomycin Indium radioisotopes Radionuclide imaging Radiation therapy Adjuvant chemotherapy Head and neck neoplasms |
本文献已被 SpringerLink 等数据库收录! |
|